Pancreatic Cancer Research

ResearcherKagoshima UniversityActive in the last 2 years

Michiyo Higashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2723-1063; OpenAlex author ID A5112002830. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
47
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper

Papers 13

  1. Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002373↗
  2. The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with … Co-author DOI 10.14670/hh-18-666↗
  3. Focal Type 2 Autoimmune Pancreatitis Mimicking Pancreatic Cancer: Treatment with Neoadjuvant Chemotherapy and Surgery. Co-author DOI 10.2169/internalmedicine.0224-22↗
  4. Next-Generation Sequencing Analysis of Pancreatic Cancer Using Residual Liquid Cytology Specimens from Endoscopic Ultrasound-Guided Fine-Needle Biopsy: A Prosp… Co-author DOI 10.3390/diagnostics13061078↗
  5. Sequential evaluation of MUC promoter methylation using next-generation sequencing-based custom-made panels in liquid-based cytology specimens of pancreatic ca… Co-author DOI 10.1002/dc.25022↗
  6. A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy. Co-author DOI 10.1038/s41598-021-87748-0↗
  7. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer. Co-author DOI 10.1016/j.pan.2019.11.015↗
  8. Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning. Co-author DOI 10.1158/1078-0432.ccr-19-1247↗
  9. Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic a… Co-author DOI 10.1007/s00330-018-5570-4↗
  10. Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000362↗
  11. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ejrad.2013.12.016↗
  12. [Examination of resectable and borderline pancreatic cancer treated with neoadjuvant chemoradiation therapy]. Co-author PMID 24393873↗
  13. Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0044108↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akihide Tanimoto · 4 shared papers, 2020–2024 · strength 0.59
  2. Shinichi Hashimoto · 4 shared papers, 2015–2023 · strength 0.52
  3. Takao Ohtsuka · 3 shared papers, 2022–2024 · strength 0.49
  4. Akio Ido · 3 shared papers, 2022–2023 · strength 0.48
  5. Hiroshi Kurahara · 4 shared papers, 2013–2024 · strength 0.41
  6. Yuko Mataki · 4 shared papers, 2013–2024 · strength 0.36
  7. Kosei Maemura · 5 shared papers, 2013–2020 · strength 0.36
  8. Shiho Arima · 2 shared papers, 2023 · strength 0.33
  9. Makoto Hinokuchi · 2 shared papers, 2023 · strength 0.33
  10. Seiya Yokoyama · 4 shared papers, 2012–2022 · strength 0.32
  11. Hiromichi Iwaya · 2 shared papers, 2022–2023 · strength 0.30
  12. Tetsuya Idichi · 2 shared papers, 2020–2024 · strength 0.29
  13. Yuto Hozaka · 1 shared paper, 2024 · strength 0.19
  14. Kosuke Fukuda · 1 shared paper, 2024 · strength 0.19
  15. Hideyuki Oi · 1 shared paper, 2024 · strength 0.19
  16. Yoshihiko Fukukura · 3 shared papers, 2014–2019 · strength 0.18
  17. Nobuhisa Maeda · 1 shared paper, 2023 · strength 0.18
  18. Suguru Yonezawa · 3 shared papers, 2012–2020 · strength 0.17
  19. Surinder K. Batra · 3 shared papers, 2012–2020 · strength 0.17
  20. Hiroyuki Takamura · 1 shared paper, 2023 · strength 0.16
  21. Jia Han · 1 shared paper, 2023 · strength 0.16
  22. Sohsuke Yamada · 1 shared paper, 2023 · strength 0.16
  23. Hiroyuki Shinchi · 2 shared papers, 2013–2020 · strength 0.13
  24. Shoji Natsugoe · 2 shared papers, 2013–2020 · strength 0.13
  25. Michael Anthony Hollingsworth · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.